Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants.

Ali-Shtayeh MS, Yaniv Z and Mahajna J (2000).

J Ethnopharmacol.

PubMed:

11025160

Anti-inflammatory activity of aqueous extracts of five Costa Rican medicinal plants in Sprague-Dawley rats.

Badilla B, Mora G and Poveda LJ (1999).

Rev Biol Trop.

PubMed:

11021310

Triterpenoid saponins from Ardisia mamillata.

Huang J et al (2000).

Phytochemistry.

PubMed:

11014272

Prolonged cardiotoxicity from poison lilly (Veratrum viride).

Prince LA and Stork CM (2000).

Vet Hum Toxicol.

PubMed:

11003119

Two major flavonoids from Ballota nigra.

Bertrand M, Tillequin F and Bailleul F (2000).

Biochem Syst Ecol.

PubMed:

10996268

Search for antiviral activity of certain medicinal plants from Córdoba, Argentina.

Zanon SM et al (1999).

Rev Latinoam Microbiol.

PubMed:

10932751

An ethnopharmacological study on common privet (Ligustrum vulgare) and phillyrea (Phillyrea latifolia).

Pieroni A and Pachaly P (2000).

Fitoterapia.

PubMed:

10930718

Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease.

Researchers evaluated the effectiveness of an Ayurveda treatment, consisting of a mixture of cow's milk with powdered Mucuna pruriens, Hyoscyamus reticulatus, Withania somnifera, and Sida cordifolia, on 18 patients clinically diagnosed with Parkinson's disease. Thirteen patients underwent cleansing and palliative therapy, while five underwent only palliative therapy. The group that underwent both therapies experienced significant improvements in daily activities and motor skills compared to the group that only received palliative therapy. The study revealed that each dose contained approximately 200mg of L-DOPA and established the importance of cleansing therapy prior to palliative therapy. This research highlights the potential benefits of Ayurveda medication in treating Parkinson's disease.

Nagashayana N et al (2000).

J Neurol Sci.

PubMed:

10930594